Organon & Co. (OGN)
6.56
-0.15
(-2.24%)
USD |
NYSE |
Mar 06, 16:00
6.60
+0.04
(+0.61%)
After-Hours: 20:00
Organon Shareholders Equity (Quarterly) : 752.00M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Merck & Co., Inc. | 52.61B |
| Amphastar Pharmaceuticals, Inc. | 788.80M |
| Plus Therapeutics, Inc. | 5.054M |
| Geron Corp. | 225.87M |
| Vertex Pharmaceuticals, Inc. | 18.67B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 12.87B |
| Total Liabilities (Quarterly) | 12.12B |
| Debt to Equity Ratio | 11.70 |
| Current Ratio | 1.821 |
| Net Debt Paydown Yield | -0.55% |